• Sonoma Pharmaceuticals received FDA 510(k) clearance for Microdacyn wound irrigation solution, expanding indications, packaging options, and multiple-use labeling.
• Clearance adds single-patient, multiple-use claims, aiming to broaden commercial opportunities in wound care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonoma Pharmaceuticals Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606300900ACCESSWRNAPR_____1184417) on June 30, 2026, and is solely responsible for the information contained therein.